Skip to Main Content

New or Updated Policies - Effective December 19, 2026

Date: 11/19/26

MHS Health Wisconsin regularly adds new or provides updates to clinical and payment policies to ensure they are designed to comply with industry standards while delivering the best experiences and outcomes for our members.You can view the details of these policies on their effective date by visiting Clinical and Payment Policies. The following new policies or policy revisions are effective December 19, 2026.

Policy #Policy NameDescriptionLine(s) of Business
CP.MP.108 Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and Beta-thalassemiaAnnual review. Added new criteria I. for transplant evaluations. Background updated with no impact to criteria. Coding and descriptions reviewed. References reviewed and updated. Reviewed by internal specialists.Medicaid;  Medicare
CP.MP.185Skin and Soft Tissue SubstitutesIn criteria IV.K.1., V.J.1., VI.I.1., and VII.J.1., specified that photographic documentation of the wound with a ruler for scale is required for follow up applications and added a requirement for a wound description, including size and depth, for initial applications. In criterion VIII.B., replaced “ulcer” with “wound.” In HCPCS Code Table 3, added the following HCPCS codes: A2046, A2047, A2048, A2049, A2050, Q4207, Q4223, and Q4243.Medicaid;  Medicare

 

View all Clinical and Payment Policies.

Thank you for being a valued partner in caring for the health and well-being of our members. If you have any questions about the policies listed above or any our Clinical & Payment Policies, please contact your Provider Relations representative or call the Provider Inquiry Line at 1-800-222-9831. If you are unsure who is your representative, please email us at WI_Provider_Relations@mhswi.com.